← Open Payments lookup

KRISTI LINDSEY: Open Payments

NPI 1891878831 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,203 in 46 payments from 10 companies in 2025. Trend: 2023 $1,332 · 2024 $1,498 · 2025 $1,203

Food & beverage: $1,126Education: $77
CompanyPaymentsAmount
Madrigal Pharmaceuticals7$298
Ardelyx, Inc.13$295
Janssen Biotech, Inc.10$264
ABBVIE INC.5$110
PFIZER INC.3$74
GENZYME CORPORATION2$47
Aimmune Therapeutics, Inc.2$36
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$35
Takeda Pharmaceuticals U.S.A., Inc.1$24
Celltrion USA Inc.1$22

Products named: REZDIFFRA, IBSRELA, TREMFYA, RINVOQ, XELJANZ, DUPIXENT, SKYRIZI, VOWST.

Industry payments across CA — which companies pay providers there.